Abstract
Approximately one in six men in the United States will develop prostate cancer during their lifetime. Genetic and environmental variables play a role in determining prostate cancer risk. This article highlights the latest evidence regarding the risk factors for prostate cancer. The current screening strategies using prostate-specific antigen and digital rectal examination are also discussed, as well as the limitations of these protocols and potential methods for improving early detection.
MeSH terms
-
Comorbidity
-
Diet
-
Dietary Supplements / adverse effects
-
Environmental Exposure / adverse effects
-
Genetic Predisposition to Disease
-
Humans
-
Male
-
Mass Screening / methods*
-
Mass Screening / standards
-
Practice Guidelines as Topic
-
Prescription Drugs / adverse effects
-
Primary Health Care*
-
Prostate-Specific Antigen / blood
-
Prostatic Neoplasms / diagnosis*
-
Prostatic Neoplasms / genetics
-
Prostatic Neoplasms / prevention & control*
-
Risk Factors
Substances
-
Prescription Drugs
-
Prostate-Specific Antigen